Congratulations to the recipient of the @ATS_GG Early Career Investigator Achievement Award Jonas C. Schupp, MD, MPVD, ATSF @jonas_schupp
Learn more at: https://t.co/c4ejsXgOi7
Finally in Print! The Official ATS Research Statement on Racial, Ethnic, Sex & Gender Equity for Inclusive Interstitial Lung Disease Research.
👏🏼 Drs Assayag, Adegonsoye, Cottin, Mageto, @ATSBlueEditor & the subcommittee members!!
#CurePF4All
https://t.co/rjA5BxVoDb
📢 Save the date! Join us on 10 Sept 2025 for an #ILDIN webinar with @drphilmol “From Calm to Crisis: ILD Acute Exacerbations”
➡️ For ILD-IN members. Registration info coming soon via email.
#ILD#ERS#LungHealth
📩 Check your emails! You'll find the booking link for the Assembly social dinner at #ERSCongress and a summary of all ILD sessions not to miss.
#ILD#ERS2025#ECM#Networking
See our Comment on: Inflammatory plasma protein levels are elevated years before sarcoidosis diagnosis 🇸🇪🇫🇷 thanks to Etienne Villain @NaderYatim @ArthurMageau@RaphaelBorie@nathanpsmad @darragh_duffy and all co-authors
https://t.co/1rBUHovOBB
⌛🎓J-5 ! Déjà 335 inscrits ✨
🆕 Formation sur les PID chez l'adulte et l'enfant
🧑⚕️ Coordonnée par : Pr Vincent Cottin
💻 2 webinaires 100% en ligne de 17h à 20h35
📅 19 et 28 novembre 2024
✔️ : https://t.co/jEOetSMkIO
Par @OrphaLung, @RespiFIL et la @SPLF_SocPneumo .
Ne manquez pas le webinaire / « ILD virtual school » de RespiFIL SPLF Orphalung - une mise à jour sur l’ensemble des PID, programme couvert tous les deux ans. Merci @SPLF_SocPneumo@RespiFIL
Elsevier is one of the largest, most hated and most influential academic publishing companies in the world.
How it started & how it's going
A thread🧵
1/8 🚨 New paper alert! Our latest study entitled “Fibroblast-derived extracellular vesicles contain SFRP1 and mediate pulmonary fibrosis” published in the @JCI_Insight is now available online https://t.co/U1fEhnNPxn